SOPHARMA AD: Current report 42 buy back 17042014

opublikowano: 2014-04-17 10:52

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Current_report_42_buy_back_17042014.doc (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		42	/	2014
	Date of issue:		2014-04-17
	Short name of the issuer
	SOPHARMA AD
	Subject
	Current report 42 buy back 17042014
	Official market - legal basis
	Art. 56 ust. 5 Ustawy o ofercie - aktualizacja informacji
	Unofficial market - legal basis
	Contents of the report:
	SOPHARMA AD (the “Company") hereby informs that from 10 April 2014 up to and including 16 April 2014 the Company bought 4 125 own shares representing 0.003% of the share capital of the Company, to the total value of 18 136.84 BGN on the Bulgarian Stock Exchange, the average price per share was 4.40 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 4 986 935, representing 3.78% of the share capital of the Company.
	Annexes
	File				Description
	Current report 42 buy back 17042014.docCurrent report 42 buy back 17042014.doc				Current report 42 buy back 17042014

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2014-04-17	Ognian Donev	Executive director